BioRestorative Announces Share Repurchase Program

Core Viewpoint - BioRestorative Therapies, Inc. has announced a stock repurchase program authorizing the repurchase of up to $2 million of its outstanding common stock, reflecting confidence in its clinical development pipeline and business outlook [1][2] Company Overview - BioRestorative is a clinical stage regenerative medicine company focused on stem cell-based therapies and products [1] - The company develops therapeutic products primarily involving adult stem cells, with core clinical programs targeting disc/spine disease and metabolic disorders [4] Clinical Development Programs - Disc/Spine Program (brtxDISC): The lead candidate, BRTX-100, is formulated from autologous cultured mesenchymal stem cells from the patient's bone marrow, intended for non-surgical treatment of lumbosacral disc disorders. A Phase 2 clinical trial for chronic lower back pain has commenced, and FDA IND clearance has been obtained for chronic cervical discogenic pain [4] - Metabolic Program (ThermoStem): This program focuses on developing cell-based therapies targeting obesity and metabolic disorders using brown adipose derived stem cells (BADSC) to generate brown adipose tissue (BAT). Initial research suggests that increased brown fat may enhance caloric burning and reduce glucose and lipid levels [5] - BioCosmeceuticals: The company operates a commercial platform for BioCosmeceuticals, with a current product that is a cell-based secretome designed to reduce fine lines and wrinkles. Future plans include expanding the product line and pursuing FDA approvals in the BioCosmeceuticals space [6] Stock Repurchase Program Details - The stock repurchase program allows the company to repurchase shares in the open market or through private transactions, with the timing and amount at management's discretion based on market conditions and other factors [2][3] - The program is intended to enhance long-term shareholder value, as the company believes its current share price does not reflect its intrinsic value [2]